Johnson & Johnson (BVMF:JNJB34)

Market Cap	2.11T
Revenue (ttm)	515.42B
Net Income (ttm)	125.84B
Shares Out	n/a
EPS (ttm)	51.84
PE Ratio	16.74
Forward PE	14.86
Dividend	1.27 (2.23%)
Ex-Dividend Date	May 27, 2025

Volume	11,548
Average Volume	3,626
Open	57.61
Previous Close	56.91
Day's Range	57.56 - 58.90
52-Week Range	52.61 - 65.90
Beta	0.41
RSI	60.65
Earnings Date	Jul 16, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: JNJB34

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD